ISIN | LU1240788064 |
---|---|
Valor Number | 28364403 |
Bloomberg Global ID | UBSSEQA LX |
Fund Name | UBS (Lux) Equity SICAV - Swiss Opportunity (CHF) (EUR) Q-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | This actively managed sub-fund invests at least two thirds of its assets in equities and equity rights of companies domiciled or chiefly active in Switzerland, regardless of market capitalisation. This sub-fund promotes environmental and/or social characteristics and complies with Article 8 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (“SFDR”). |
Peculiarities |
Current Price * | 209.86 EUR | 30.06.2025 |
---|---|---|
Previous Price * | 210.09 EUR | 27.06.2025 |
52 Week High * | 217.78 EUR | 03.03.2025 |
52 Week Low * | 186.85 EUR | 07.04.2025 |
NAV * | 209.86 EUR | 30.06.2025 |
Issue Price * | 209.86 EUR | 30.06.2025 |
Redemption Price * | 209.86 EUR | 30.06.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 58,605,792 | |
Unit/Share Assets *** | 1,369,615 | |
Trading Information SIX |
YTD Performance | +6.46% |
30.12.2024 - 30.06.2025
30.12.2024 30.06.2025 |
---|---|---|
YTD Performance (in CHF) | +5.70% |
30.12.2024 - 30.06.2025
30.12.2024 30.06.2025 |
1 month | -1.85% |
30.05.2025 - 30.06.2025
30.05.2025 30.06.2025 |
3 months | +0.69% |
31.03.2025 - 30.06.2025
31.03.2025 30.06.2025 |
6 months | +6.46% |
30.12.2024 - 30.06.2025
30.12.2024 30.06.2025 |
1 year | +8.52% |
01.07.2024 - 30.06.2025
01.07.2024 30.06.2025 |
2 years | +15.79% |
30.06.2023 - 30.06.2025
30.06.2023 30.06.2025 |
3 years | +28.95% |
30.06.2022 - 30.06.2025
30.06.2022 30.06.2025 |
5 years | +48.02% |
30.06.2020 - 30.06.2025
30.06.2020 30.06.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 9.87% | |
---|---|---|
Novartis AG Registered Shares | 9.75% | |
Nestle SA | 9.58% | |
Zurich Insurance Group AG | 8.75% | |
UBS Group AG | 4.93% | |
Swiss Re AG | 4.87% | |
Lonza Group Ltd | 4.79% | |
Swiss Life Holding AG | 4.39% | |
ABB Ltd | 4.09% | |
Compagnie Financiere Richemont SA Class A | 2.97% | |
Last data update | 30.04.2025 |
TER | 1.09% |
---|---|
TER date | 31.05.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.82% |
Ongoing Charges *** | 1.10% |
SRRI ***
|
|
SRRI date *** | 31.05.2025 |